Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Influenza

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 295 articles: HTML format

Single Articles

February 2026
1. LIU C, Zheng J, Wang Y, Beck F, et al
   Cryo-EM structure of locked spike glycoprotein from bat SARS-like coronavirus WIV1, molecular dynamics and biophysics across host range.
   Proc Natl Acad Sci U S A. 2026;123:e2516874123.
   PubMed     Abstract available
   
   
   
2. HANSEN LH, Jorgensen F, Bang Petersen M
   The psychological ability to adopt recommended coping responses reduced infections during the COVID-19 pandemic.
   Proc Natl Acad Sci U S A. 2026;123:e2415344123.
   PubMed     Abstract available
   
   
   
3. WANG X, Jing X, Guo Z, Long S, et al
   Coviretinopathy: COVID-19-induced VEGF-dependent retinopathy.
   Proc Natl Acad Sci U S A. 2026;123:e2516405123.
   PubMed     Abstract available
   
   
   
4. KIM AS, Ma K, Reinhardt CJ, Lazar DC, et al
   Integrated phenotypic screening and chemical proteomics identifies ETF1 ligands that modulate viral translation and replication.
   Proc Natl Acad Sci U S A. 2026;123:e2524108123.
   PubMed     Abstract available
   
   
   
5. WANG J, Tai W, Wang Z, Dai W, et al
   SARS-CoV-2 S assembly into virions facilitated by host ERM proteins.
   Proc Natl Acad Sci U S A. 2026;123:e2504517123.
   PubMed     Abstract available
   
   
   January 2026
6. TE N, Chin AWH, Gu H, Zhirong Jia J, et al
   Broad beta-CoV immunity and transmission blockade by a single-dose live-attenuated vaccine with atypical codon usage.
   Proc Natl Acad Sci U S A. 2026;123:e2518645123.
   PubMed     Abstract available
   
   
   
7. SRINIVASAN S, King J, Collins JM, Colubri A, et al
   Real-time spatiotemporal tracking of infectious outbreaks in confined environments with a host-pathogen agent-based system.
   Proc Natl Acad Sci U S A. 2026;123:e2422574123.
   PubMed     Abstract available
   
   
   
8. ZHANG Y, Silvestre-Roig C, Fu H, Alimohamadi H, et al
   SARS-CoV-2 peptide fragments selectively dysregulate specific immune cell populations via Gaussian curvature targeting.
   Proc Natl Acad Sci U S A. 2026;123:e2521841122.
   PubMed     Abstract available
   
   
   
9. VERMA AK, Tan L, Schuster N, Moye SL, et al
   Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection.
   Proc Natl Acad Sci U S A. 2026;123:e2530209123.
   PubMed     Abstract available
   
   
   
10. ZHANG R, Deng R, Liu S, Yao Q, et al
    Reconstructing the early spatial spread of pandemic respiratory viruses in the United States.
    Proc Natl Acad Sci U S A. 2026;123:e2518051123.
    PubMed     Abstract available
    
    
    
11. ARNING N, Fryer HR, Wilson DJ
    Identifying direct risk factors in UK Biobank via simultaneous Bayesian-frequentist model-averaged hypothesis testing using Doublethink.
    Proc Natl Acad Sci U S A. 2026;123:e2514138122.
    PubMed     Abstract available
    
    
    
12. WIATR M, Wang Z, Canis M, Hernandez B, et al
    Memory B cell development in response to mRNA SARS-CoV-2 and nanoparticle immunization in mice.
    Proc Natl Acad Sci U S A. 2026;123:e2527869123.
    PubMed     Abstract available
    
    
    
13. PARK SW, Nielsen BF, Howerton E, Grenfell BT, et al
    Susceptible host dynamics explain pathogen resilience to perturbations.
    Proc Natl Acad Sci U S A. 2026;123:e2517518122.
    PubMed     Abstract available
    
    
    
14. RIVERA-CARDONA J, Mahajan T, Thayer EA, Kakuturu NR, et al
    Intrinsic OASL expression governs heterogeneity in interferon induction during influenza A virus infection.
    Proc Natl Acad Sci U S A. 2026;123:e2509560123.
    PubMed     Abstract available
    
    
    December 2025
15. XING Q, Lu L, Wang L, Chen F, et al
    Country-specific progress toward the Sustainable Development Goals: Past, present, and prospects.
    Proc Natl Acad Sci U S A. 2025;122:e2524299122.
    PubMed     Abstract available
    
    
    
16. NIELSEN BF, Park SW, Howerton E, Lorentzen OF, et al
    Complex multiannual cycles of Mycoplasma pneumoniae: Persistence and the role of stochasticity.
    Proc Natl Acad Sci U S A. 2025;122:e2509184122.
    PubMed     Abstract available
    
    
    
17. PETROVA B, Syphurs C, Culhane AJ, Chen J, et al
    MTHFR allele and one-carbon metabolic profile predict severity of COVID-19.
    Proc Natl Acad Sci U S A. 2025;122:e2509118122.
    PubMed     Abstract available
    
    
    
18. DIAMANT ES, Yeh PJ
    Rapid morphological change in an urban bird due to COVID-19 restrictions.
    Proc Natl Acad Sci U S A. 2025;122:e2520996122.
    PubMed     Abstract available
    
    
    
19. OKADA T, Isacchini G, Yu Q, Hallatschek O, et al
    Uncovering heterogeneous intercommunity disease transmission from neutral allele frequency time series.
    Proc Natl Acad Sci U S A. 2025;122:e2500663122.
    PubMed     Abstract available
    
    
    
20. CAI J, Wu Y, Liu H, Deng Z, et al
    China's post-zero-COVID Omicron wave: A Bayesian analysis.
    Proc Natl Acad Sci U S A. 2025;122:e2514157122.
    PubMed     Abstract available
    
    
    
21. CAPUCETTI A, Falivene J, Pizzichetti C, Latino I, et al
    Tattoo ink induces inflammation in the draining lymph node and alters the immune response to vaccination.
    Proc Natl Acad Sci U S A. 2025;122:e2510392122.
    PubMed     Abstract available
    
    
    
22. JAMIESON KH, Gibson LA, Jamieson PE, Patterson S Jr, et al
    Using a mental model approach to undercut the effects of exposure to mRNA vaccination misconceptions: Two randomized trials.
    Proc Natl Acad Sci U S A. 2025;122:e2517067122.
    PubMed     Abstract available
    
    
    November 2025
23. HOLEC PV, Breuckman KC, Leddy O, White FM, et al
    High-throughput screening for class I peptide MHC binding via yeast surface display.
    Proc Natl Acad Sci U S A. 2025;122:e2514741122.
    PubMed     Abstract available
    
    
    
24. BI K, Bandekar SR, Bouchnita A, Cramer A, et al
    Estimated impact of 2022-2023 influenza vaccines on annual hospital burden in the United States.
    Proc Natl Acad Sci U S A. 2025;122:e2505175122.
    PubMed     Abstract available
    
    
    
25. LI J, Wang M, Yang Y, Zhang L, et al
    Structural basis for a potent human neutralizing antibody targeting a conserved epitope on the H7 hemagglutinin head.
    Proc Natl Acad Sci U S A. 2025;122:e2503008122.
    PubMed     Abstract available
    
    
    
26. HARMAND TJ, Pietrok L, Rich H, Deshycka R, et al
    A multivalent nanobody-drug conjugate to prevent and treat influenza virus infections.
    Proc Natl Acad Sci U S A. 2025;122:e2409565122.
    PubMed     Abstract available
    
    
    
27. CHO E, Davis MA, Nowak JA, Izzo M, et al
    Modulating antigen processing through metal-organic frameworks to bias adaptive immunity.
    Proc Natl Acad Sci U S A. 2025;122:e2409555122.
    PubMed     Abstract available
    
    
    October 2025
28. FORMIGA RO, Pesenti L, de la Heronniere FC, Ladjemi MZ, et al
    Cytosolic proliferating cell nuclear antigen (PCNA) orchestrates neutrophil hyperactivation in COVID-19.
    Proc Natl Acad Sci U S A. 2025;122:e2503667122.
    PubMed     Abstract available
    
    
    
29. POLYCARPOU A, Wagner-Gamble T, Greenlaw R, O'Neill L, et al
    Glycan recognition by collectin-11 drives SARS-CoV-2 infectivity and membrane injury of respiratory epithelial cells.
    Proc Natl Acad Sci U S A. 2025;122:e2521209122.
    PubMed     Abstract available
    
    
    
30. GIBSON GC, Fox SJ, Javan E, Ptak SE, et al
    Improving outbreak forecasts through model augmentation.
    Proc Natl Acad Sci U S A. 2025;122:e2508575122.
    PubMed     Abstract available
    
    
    
31. MCKELLAR J, Cadenes J, Garcia de Gracia F, Aube C, et al
    Human MX1 orchestrates the cytoplasmic sequestration of neosynthesized influenza A virus vRNPs.
    Proc Natl Acad Sci U S A. 2025;122:e2418935122.
    PubMed     Abstract available
    
    
    
32. LIU S, Yan L, Du W, Liu W, et al
    Manifold-constrained nucleus-level denoising diffusion model for structure-based drug design.
    Proc Natl Acad Sci U S A. 2025;122:e2415666122.
    PubMed     Abstract available
    
    
    
33. YANG Y, Li Y, Becker ST, Khan A, et al
    Molecular basis of SARS-CoV-2 proofreading enzyme-mediated resistance to remdesivir.
    Proc Natl Acad Sci U S A. 2025;122:e2519755122.
    PubMed     Abstract available
    
    
    
34. LV H, Teo QW, Pholcharee T, Liu W, et al
    Molecular divergence and convergence of mammalian antibody responses to the influenza virus hemagglutinin stem.
    Proc Natl Acad Sci U S A. 2025;122:e2510927122.
    PubMed     Abstract available
    
    
    September 2025
35. FAN W, Zhang Y, Gautron L, Thomas DG, et al
    FGF21 acting on the noradrenergic nervous system protects against influenza virus infection.
    Proc Natl Acad Sci U S A. 2025;122:e2522045122.
    PubMed     Abstract available
    
    
    
36. 
    Correction for Yeh et al., Three things we can do now to reduce the risk of avian influenza spillovers.
    Proc Natl Acad Sci U S A. 2025;122:e2524485122.
    PubMed    
    
    
    
37. MORIYAMA M, Rodrigues G, Wang J, Jayewickreme R, et al
    Intranasal hemagglutinin protein boosters induce protective mucosal immunity against influenza A viruses in mice.
    Proc Natl Acad Sci U S A. 2025;122:e2422171122.
    PubMed     Abstract available
    
    
    
38. MARTINEZ-GONZALEZ B, Soria ME, de Avila AI, Somovilla P, et al
    SARS-CoV-2 mutant spectrum complexity is an epidemiologically evolvable trait.
    Proc Natl Acad Sci U S A. 2025;122:e2515706122.
    PubMed     Abstract available
    
    
    
39. VILLAREJO-TORRES M, Nombela-Diaz I, Munoz-Santos D, Ruiz-Yuste M, et al
    SARS-CoV-2-derived RNA replicons as safe and effective vaccines.
    Proc Natl Acad Sci U S A. 2025;122:e2516587122.
    PubMed     Abstract available
    
    
    
40. SWINGLE KL, Hamilton AG, Han X, Liao KC, et al
    Circular RNA lipid nanoparticle vaccine against SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2025;122:e2505718122.
    PubMed     Abstract available
    
    
    
41. YOSHIDA A, Uekusa Y, Suzuki T, Bauer M, et al
    Enhanced visualization of influenza A virus entry into living cells using virus-view atomic force microscopy.
    Proc Natl Acad Sci U S A. 2025;122:e2500660122.
    PubMed     Abstract available
    
    
    
42. JIANG Z, Pan W, Chen Y, Zhou D, et al
    ApoD mediates age-associated increase in vulnerability to influenza virus infection.
    Proc Natl Acad Sci U S A. 2025;122:e2423973122.
    PubMed     Abstract available
    
    
    
43. LINOS E, Lasky-Fink J, Dorie V, Rothstein J, et al
    Interventions to bolster benefits take-up: Assessing intensity, framing, and targeting of government outreach.
    Proc Natl Acad Sci U S A. 2025;122:e2504747122.
    PubMed     Abstract available
    
    
    
44. URMI T, Pant B, Dewey G, Quintana-Mathe A, et al
    Characterizing population-level changes in human behavior during the COVID-19 pandemic in the United States.
    Proc Natl Acad Sci U S A. 2025;122:e2500655122.
    PubMed     Abstract available
    
    
    
45. ROWNTREE LC, Allen LF, Hagen RR, McQuilten HA, et al
    HLA-B*15:01-positive severe COVID-19 patients lack CD8(+) T cell pools with highly expanded public clonotypes.
    Proc Natl Acad Sci U S A. 2025;122:e2503145122.
    PubMed     Abstract available
    
    
    
46. WANG S, Sun H, Wang Y, Wang Z, et al
    Broad neutralizing antibody response of a monomeric spike-based SARS-CoV-2 bivalent vaccine against diverse variants.
    Proc Natl Acad Sci U S A. 2025;122:e2503254122.
    PubMed     Abstract available
    
    
    
47. 
    Correction for Soni et al., BIK polymorphism and proteasome regulation unveil host risk factor for severe influenza.
    Proc Natl Acad Sci U S A. 2025;122:e2521789122.
    PubMed    
    
    
    
48. LI Y, Wang Z, Wang J, Jiang Z, et al
    ARRDC4-mediated glycolysis enhances innate immunity to influenza A virus through fructose-1,6-bisphosphate.
    Proc Natl Acad Sci U S A. 2025;122:e2512385122.
    PubMed     Abstract available
    
    
    
49. WAN Z, Li C, Zhou Y, Yu Y, et al
    Organoid-based neutralization assays reveal a distinctive profile of SARS-CoV-2 antibodies and recapitulate the real-world efficacy.
    Proc Natl Acad Sci U S A. 2025;122:e2509616122.
    PubMed     Abstract available
    
    
    
50. VICARY AC, Jordan SNZ, Mendes M, Swaminath S, et al
    CRISPR with Transcriptional Readout reveals influenza transcription is modulated by NELF and can precipitate an interferon response.
    Proc Natl Acad Sci U S A. 2025;122:e2515564122.
    PubMed     Abstract available
    
    
    
51. MARKOWITZ DM, Mazzuchi T, Syropoulos S, Law KF, et al
    An exploration of basic human values in 38 million obituaries over 30 years.
    Proc Natl Acad Sci U S A. 2025;122:e2510318122.
    PubMed     Abstract available
    
    
    August 2025
52. YIN S, Zhang C, Teitelbaum CS, Si Y, et al
    Landscape changes elevate the risk of avian influenza virus diversification and emergence in the East Asian-Australasian Flyway.
    Proc Natl Acad Sci U S A. 2025;122:e2503427122.
    PubMed     Abstract available
    
    
    
53. XU Y, Anirudhan V, Gaisina IN, Du H, et al
    Mechanistic insights into the small-molecule inhibition of influenza A virus entry.
    Proc Natl Acad Sci U S A. 2025;122:e2503899122.
    PubMed     Abstract available
    
    
    
54. LYU L, Gill M, Stott G, Subedi S, et al
    Tracing SARS-CoV-2 clusters across local scales using genomic data.
    Proc Natl Acad Sci U S A. 2025;122:e2501435122.
    PubMed     Abstract available
    
    
    
55. HSU CC, Chamblee M, Ye C, Shamseldin MM, et al
    Intranasal measles virus- and mumps virus-based SARS-CoV-2 vaccine candidates prevent SARS-CoV-2 infection and transmission.
    Proc Natl Acad Sci U S A. 2025;122:e2506821122.
    PubMed     Abstract available
    
    
    
56. MCGUIRE DJ, Akondy RS, Yang S, Edupuganti S, et al
    Regulation of CD45 isoforms during human effector and memory CD8 T cell differentiation: Implications for T cell nomenclature.
    Proc Natl Acad Sci U S A. 2025;122:e2322982122.
    PubMed     Abstract available
    
    
    
57. ASLAM S, Sanchez-Aparicio MT, Siempelkamp BD, Dornan GL, et al
    Influenza A virus NS1 protein mimics oncogenic PI3K resulting in isoform specific cellular redistribution and activation.
    Proc Natl Acad Sci U S A. 2025;122:e2423066122.
    PubMed     Abstract available
    
    
    
58. LAHIRI H, Israeli E, Krugliak M, Basu K, et al
    A bacteria-based search for drugs against avian and swine flu yields a potent and resistance-resilient channel blocker.
    Proc Natl Acad Sci U S A. 2025;122:e2502240122.
    PubMed     Abstract available
    
    
    
59. YEH KB, Bahnfleth WP, Bradforda E, Cardona C, et al
    Three things we can do now to reduce the risk of avian influenza spillovers.
    Proc Natl Acad Sci U S A. 2025;122:e2503565122.
    PubMed    
    
    
    
60. SAKURAI Y, Fujioka Y, Maishi N, Takeda R, et al
    SARS-CoV-2 uptake and inflammatory response in senescent endothelial cells are regulated by the BSG/VEGFR2 pathway.
    Proc Natl Acad Sci U S A. 2025;122:e2502724122.
    PubMed     Abstract available
    
    
    July 2025
61. LEE AS
    Stress-induced translocation of the endoplasmic reticulum chaperone GRP78/BiP and its impact on human disease and therapy.
    Proc Natl Acad Sci U S A. 2025;122:e2412246122.
    PubMed     Abstract available
    
    
    
62. MENON T, McQuilten HA, Samir J, Nguyen THO, et al
    Central memory T cells with key TCR repertoires and gene expression profiles dominate influenza CD8+ T cell pools across the human lifespan.
    Proc Natl Acad Sci U S A. 2025;122:e2501167122.
    PubMed     Abstract available
    
    
    
63. KOREN O, Weidmann NB
    Infectious disease outbreaks drive political mistrust.
    Proc Natl Acad Sci U S A. 2025;122:e2506093122.
    PubMed     Abstract available
    
    
    
64. MEISTER TL, Nocke MK, Heinen N, Burkard TL, et al
    Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants.
    Proc Natl Acad Sci U S A. 2025;122:e2500276122.
    PubMed     Abstract available
    
    
    
65. SHANKAR V, Wilhelmy J, Curtis EJ, Michael B, et al
    Oxidative stress is a shared characteristic of ME/CFS and Long COVID.
    Proc Natl Acad Sci U S A. 2025;122:e2426564122.
    PubMed     Abstract available
    
    
    
66. YANG B, Hu A, Wang T, Chen X, et al
    SARS-CoV-2 infection induces ZBP1-dependent PANoptosis in bystander cells.
    Proc Natl Acad Sci U S A. 2025;122:e2500208122.
    PubMed     Abstract available
    
    
    
67. SONI S, Yildiz S, Allen EK, Petersen H, et al
    BIK polymorphism and proteasome regulation unveil host risk factor for severe influenza.
    Proc Natl Acad Sci U S A. 2025;122:e2424367122.
    PubMed     Abstract available
    
    
    
68. ECKEY M, Li P, Morrison B, Bergquist J, et al
    Patient-reported treatment outcomes in ME/CFS and long COVID.
    Proc Natl Acad Sci U S A. 2025;122:e2426874122.
    PubMed     Abstract available
    
    
    
69. RAMOS KE, Nandigrami P, Najafian A, Lai JR, et al
    Optimization of a sarbecovirus llama nanobody-antigen binding interface via a combined computational and phage display protein engineering approach.
    Proc Natl Acad Sci U S A. 2025;122:e2426438122.
    PubMed     Abstract available
    
    
    
70. AKSOY CG, Barrero JM, Bloom N, Davis SJ, et al
    The global persistence of work from home.
    Proc Natl Acad Sci U S A. 2025;122:e2509892122.
    PubMed     Abstract available
    
    
    
71. KAO KS, Pihlstrom NL, Niejadlik EG, Cantaert T, et al
    FcgammaRIIIa is a noncanonical costimulatory molecule for CD8 T cells.
    Proc Natl Acad Sci U S A. 2025;122:e2509016122.
    PubMed     Abstract available
    
    
    
72. KRAUSE NM, Freiling I, Scheufele DA
    Our changing information ecosystem for science and why it matters for effective science communication.
    Proc Natl Acad Sci U S A. 2025;122:e2400928121.
    PubMed     Abstract available
    
    
    
73. JURASZEK J, Kadam RU, Branduardi D, van Ameijde J, et al
    De novo design of D-peptide ligands: Application to influenza virus hemagglutinin.
    Proc Natl Acad Sci U S A. 2025;122:e2426554122.
    PubMed     Abstract available
    
    
    
74. GUTMANN T, Kuster D, Hyman AA
    SARS-CoV-2 nucleocapsid protein directly prevents cGAS-DNA recognition through competitive binding.
    Proc Natl Acad Sci U S A. 2025;122:e2426204122.
    PubMed     Abstract available
    
    
    June 2025
75. GE X, Hou Y
    Social influence during public crises: Weekly dynamics and adaptive patterns of conformity to the collective following the COVID-19 outbreak.
    Proc Natl Acad Sci U S A. 2025;122:e2500008122.
    PubMed     Abstract available
    
    
    
76. CAOBI A, Su CM, Beusch CM, Kenney D, et al
    SARS-CoV-2 nsp15 enhances viral virulence by subverting host antiviral defenses.
    Proc Natl Acad Sci U S A. 2025;122:e2426528122.
    PubMed     Abstract available
    
    
    
77. GOZZI N, Perra N, Vespignani A
    Comparative evaluation of behavioral epidemic models using COVID-19 data.
    Proc Natl Acad Sci U S A. 2025;122:e2421993122.
    PubMed     Abstract available
    
    
    
78. HUOT M, Wang D, Liu J, Shakhnovich EI, et al
    Predicting high-fitness viral protein variants with Bayesian active learning and biophysics.
    Proc Natl Acad Sci U S A. 2025;122:e2503742122.
    PubMed     Abstract available
    
    
    
79. HUANG P, Almquist ZW, Butts CT
    Endogenous competition and the underrealized reproduction of infectious diseases.
    Proc Natl Acad Sci U S A. 2025;122:e2502676122.
    PubMed     Abstract available
    
    
    May 2025
80. FAN C, Keeffe JR, Malecek KE, Cohen AA, et al
    Cross-reactive sarbecovirus antibodies induced by mosaic RBD nanoparticles.
    Proc Natl Acad Sci U S A. 2025;122:e2501637122.
    PubMed     Abstract available
    
    
    
81. GRANULO A, Fuchs C, Bohm R
    Psychological reactance to system-level policies before and after their implementation.
    Proc Natl Acad Sci U S A. 2025;122:e2409907122.
    PubMed     Abstract available
    
    
    
82. CHI G, Abel GJ, Johnston D, Giraudy E, et al
    Measuring global migration flows using online data.
    Proc Natl Acad Sci U S A. 2025;122:e2409418122.
    PubMed     Abstract available
    
    
    April 2025
83. BONTORIN S, Centellegher S, Gallotti R, Pappalardo L, et al
    Mixing individual and collective behaviors to predict out-of-routine mobility.
    Proc Natl Acad Sci U S A. 2025;122:e2414848122.
    PubMed     Abstract available
    
    
    
84. HUANG QJ, Kim R, Song K, Grigorieff N, et al
    Virion-associated influenza hemagglutinin clusters upon sialic acid binding visualized by cryoelectron tomography.
    Proc Natl Acad Sci U S A. 2025;122:e2426427122.
    PubMed     Abstract available
    
    
    
85. RIOS CARRASCO M, Lin TH, Zhu X, Gabarroca Garcia A, et al
    The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors.
    Proc Natl Acad Sci U S A. 2025;122:e2419800122.
    PubMed     Abstract available
    
    
    
86. LIU X, Balligand T, Le Gall C, Ploegh HL, et al
    A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses.
    Proc Natl Acad Sci U S A. 2025;122:e2424889122.
    PubMed     Abstract available
    
    
    
87. GUAY B, Marghetis T, Wong C, Landy D, et al
    Quirks of cognition explain why we dramatically overestimate the size of minority groups.
    Proc Natl Acad Sci U S A. 2025;122:e2413064122.
    PubMed     Abstract available
    
    
    March 2025
88. GAILLETON R, Mathew NR, Reusch L, Schon K, et al
    Ectopic germinal centers in the nasal turbinates contribute to B cell immunity to intranasal viral infection and vaccination.
    Proc Natl Acad Sci U S A. 2025;122:e2421724122.
    PubMed     Abstract available
    
    
    
89. EILERSEN A, Bjornstad ON, Li R, Schreiber SJ, et al
    Epidemic evolutionarily stable strategies within an age-structured host population.
    Proc Natl Acad Sci U S A. 2025;122:e2418170122.
    PubMed     Abstract available
    
    
    
90. DOS S P ANDRADE AC, Lacasse E, Dubuc I, Gudimard L, et al
    Deficiency in platelet 12-lipoxygenase exacerbates inflammation and disease severity during SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2025;122:e2420441122.
    PubMed     Abstract available
    
    
    
91. WANG Q, Xu S, Shen W, Wei Y, et al
    N6-methyladnosine of vRNA facilitates influenza A virus replication by promoting the interaction of vRNA with polymerase proteins.
    Proc Natl Acad Sci U S A. 2025;122:e2411554122.
    PubMed     Abstract available
    
    
    
92. MA Y, Wang J, Cui F, Tang L, et al
    Independent and combined effects of long-term air pollution exposure and genetic predisposition on COVID-19 severity: A population-based cohort study.
    Proc Natl Acad Sci U S A. 2025;122:e2421513122.
    PubMed     Abstract available
    
    
    
93. SCHNYDER SK, Molina JJ, Yamamoto R, Turner MS, et al
    Understanding Nash epidemics.
    Proc Natl Acad Sci U S A. 2025;122:e2409362122.
    PubMed     Abstract available
    
    
    
94. ZHU Y, Cong Y, Sun Y, Sheng S, et al
    Molecular patterns of matrix protein 1 (M1): A strong predictor of adaptive evolution in H9N2 avian influenza viruses.
    Proc Natl Acad Sci U S A. 2025;122:e2423983122.
    PubMed     Abstract available
    
    
    February 2025
95. GONZALES JE 2ND, Kim I, Bastiray A, Hwang W, et al
    Evolutionary rewiring of the dynamic network underpinning allosteric epistasis in NS1 of the influenza A virus.
    Proc Natl Acad Sci U S A. 2025;122:e2410813122.
    PubMed     Abstract available
    
    
    
96. BRENNECKE B, Civili B, Sabale PM, Barluenga S, et al
    Self-assembled proteomimetic (SAP) with antibody-like binding from short PNA-peptide conjugates.
    Proc Natl Acad Sci U S A. 2025;122:e2412850122.
    PubMed     Abstract available
    
    
    
97. NGUYEN YTK, Zhu X, Han J, Rodriguez AJ, et al
    Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens.
    Proc Natl Acad Sci U S A. 2025;122:e2416628122.
    PubMed     Abstract available
    
    
    
98. LIAO Y, Ma H, Wang Z, Wang S, et al
    Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering.
    Proc Natl Acad Sci U S A. 2025;122:e2406659122.
    PubMed     Abstract available
    
    
    January 2025
99. DUCH RM, Loewen P, Robinson TS, Zakharov A, et al
    Governing in the face of a global crisis: When do voters punish and reward incumbent governments?
    Proc Natl Acad Sci U S A. 2025;122:e2405021122.
    PubMed     Abstract available
    
    
    
100. KIRBY MB, Petersen BM, Faris JG, Kells SP, et al
     Retrospective SARS-CoV-2 human antibody development trajectories are largely sparse and permissive.
     Proc Natl Acad Sci U S A. 2025;122:e2412787122.
     PubMed     Abstract available
     
     
     
101. FERRERI LM, Seibert B, Caceres CJ, Patatanian K, et al
     Dispersal of influenza virus populations within the respiratory tract shapes their evolutionary potential.
     Proc Natl Acad Sci U S A. 2025;122:e2419985122.
     PubMed     Abstract available
     
     
     
102. NAKAMURA S, Tanimura Y, Nomura R, Suzuki H, et al
     Structure-guided engineering of a mutation-tolerant inhibitor peptide against variable SARS-CoV-2 spikes.
     Proc Natl Acad Sci U S A. 2025;122:e2413465122.
     PubMed     Abstract available
     
     
     
103. YAN S, Schlick T
     Heterogeneous and multiple conformational transition pathways between pseudoknots of the SARS-CoV-2 frameshift element.
     Proc Natl Acad Sci U S A. 2025;122:e2417479122.
     PubMed     Abstract available
     
     
     
104. SCHULZ S, Tan TJC, Wu NC, Wang S, et al
     Epistatic hotspots organize antibody fitness landscape and boost evolvability.
     Proc Natl Acad Sci U S A. 2025;122:e2413884122.
     PubMed     Abstract available
     
     
     
105. MAZIGI O, Langley DB, Henry JY, Burnett DL, et al
     Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies.
     Proc Natl Acad Sci U S A. 2025;122:e2417544121.
     PubMed     Abstract available
     
     
     
106. SINGH R, Im C, Qiu Y, Mackness B, et al
     Learning the language of antibody hypervariability.
     Proc Natl Acad Sci U S A. 2025;122:e2418918121.
     PubMed     Abstract available
     
     
     December 2024
107. 
     Correction for Rockey et al., Ventilation does not affect close-range transmission of influenza virus in a ferret playpen setup.
     Proc Natl Acad Sci U S A. 2024;121:e2424158121.
     PubMed    
     
     
     
108. GLAUBITZ A, Fu F
     Social dilemma of nonpharmaceutical interventions: Determinants of dynamic compliance and behavioral shifts.
     Proc Natl Acad Sci U S A. 2024;121:e2407308121.
     PubMed     Abstract available
     
     
     
109. KLEIN EY, Impalli I, Poleon S, Denoel P, et al
     Global trends in antibiotic consumption during 2016-2023 and future projections through 2030.
     Proc Natl Acad Sci U S A. 2024;121:e2411919121.
     PubMed     Abstract available
     
     
     
110. TOPPER MJ, Guarnieri JW, Haltom JA, Chadburn A, et al
     Lethal COVID-19 associates with RAAS-induced inflammation for multiple organ damage including mediastinal lymph nodes.
     Proc Natl Acad Sci U S A. 2024;121:e2401968121.
     PubMed     Abstract available
     
     
     
111. 
     Correction for Shahriar et al., Targeted recruitment of immune effector cells for rapid eradication of influenza virus infections.
     Proc Natl Acad Sci U S A. 2024;121:e2422717121.
     PubMed    
     
     
     
112. ABT ER, Lam AK, Noguchi M, Rashid K, et al
     Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire.
     Proc Natl Acad Sci U S A. 2024;121:e2406332121.
     PubMed     Abstract available
     
     
     November 2024
113. MEHMOOD S, Naseer S, Chen DL
     Teacher vaccinations enhance student achievement in Pakistan: The role of role models and theory of mind.
     Proc Natl Acad Sci U S A. 2024;121:e2406034121.
     PubMed     Abstract available
     
     
     
114. LIU L, Cui Z, Kunreuther H, Heal G, et al
     Modeling and testing strategic interdependence and tipping in public policy implementation.
     Proc Natl Acad Sci U S A. 2024;121:e2414041121.
     PubMed     Abstract available
     
     
     
115. IYANIWURA SA, Ribeiro RM, Zitzmann C, Phan T, et al
     The kinetics of SARS-CoV-2 infection based on a human challenge study.
     Proc Natl Acad Sci U S A. 2024;121:e2406303121.
     PubMed     Abstract available
     
     
     
116. NGUYEN MH, Palfy G, Fogeron ML, Ninot Pedrosa M, et al
     Analysis of the structure and interactions of the SARS-CoV-2 ORF7b accessory protein.
     Proc Natl Acad Sci U S A. 2024;121:e2407731121.
     PubMed     Abstract available
     
     
     
117. ZHANG H, Wang Z, Nguyen HTT, Cornejo Pontelli M, et al
     Facilitating and restraining virus infection using cell-attachable soluble viral receptors.
     Proc Natl Acad Sci U S A. 2024;121:e2414583121.
     PubMed     Abstract available
     
     
     
118. GARAIZAR A, Diaz-Oviedo D, Zablowsky N, Rissanen S, et al
     Toward understanding lipid reorganization in RNA lipid nanoparticles in acidic environments.
     Proc Natl Acad Sci U S A. 2024;121:e2404555121.
     PubMed     Abstract available
     
     
     October 2024
119. WAN J, Wang C, Wang Z, Wang L, et al
     CXCL13 promotes broad immune responses induced by circular RNA vaccines.
     Proc Natl Acad Sci U S A. 2024;121:e2406434121.
     PubMed     Abstract available
     
     
     
120. BAO L, Cao J, Gangadharan L, Huang D, et al
     Effects of lockdowns in shaping socioeconomic behaviors.
     Proc Natl Acad Sci U S A. 2024;121:e2405934121.
     PubMed     Abstract available
     
     
     
121. BISHT P, Gallagher MD, Barrasa MI, Boucau J, et al
     Abortive infection of bat fibroblasts with SARS-CoV-2.
     Proc Natl Acad Sci U S A. 2024;121:e2406773121.
     PubMed     Abstract available
     
     
     
122. PAIARDI G, Ferraz M, Rusnati M, Wade RC, et al
     The accomplices: Heparan sulfates and N-glycans foster SARS-CoV-2 spike:ACE2 receptor binding and virus priming.
     Proc Natl Acad Sci U S A. 2024;121:e2404892121.
     PubMed     Abstract available
     
     
     
123. KESSLER S, Stegen P, Zhan S, Schwemmle M, et al
     Jamaican fruit bats mount a stable and highly neutralizing antibody response after bat influenza virus infection.
     Proc Natl Acad Sci U S A. 2024;121:e2413619121.
     PubMed     Abstract available
     
     
     
124. 
     Editorial Expression of Concern: SARS-CoV-2 requires acidic pH to infect cells.
     Proc Natl Acad Sci U S A. 2024;121:e2417740121.
     PubMed    
     
     
     
125. SHAHRIAR I, Kamra M, Kanduluru AK, Campbell CL, et al
     Targeted recruitment of immune effector cells for rapid eradication of influenza virus infections.
     Proc Natl Acad Sci U S A. 2024;121:e2408469121.
     PubMed     Abstract available
     
     
     
126. FITZGERALD J
     US states that mandated COVID-19 vaccination see higher, not lower, take-up of COVID-19 boosters and flu vaccines.
     Proc Natl Acad Sci U S A. 2024;121:e2403758121.
     PubMed    
     
     
     
127. RAINS SA, Richards AS
     Reply to Fitzgerald: COVID-19 vaccine mandates and voluntary vaccination behavior.
     Proc Natl Acad Sci U S A. 2024;121:e2409246121.
     PubMed    
     
     
     
128. GAO M, Skolnick J
     Improved deep learning prediction of antigen-antibody interactions.
     Proc Natl Acad Sci U S A. 2024;121:e2410529121.
     PubMed     Abstract available
     
     
     
129. DRAGOTAKES Q, Johnson PW, Buras MR, Carter RE, et al
     Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma.
     Proc Natl Acad Sci U S A. 2024;121:e2414957121.
     PubMed     Abstract available
     
     
     
130. ASOR R, Olerinyova A, Burnap SA, Kushwah MS, et al
     Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition.
     Proc Natl Acad Sci U S A. 2024;121:e2403260121.
     PubMed     Abstract available
     
     
     September 2024
131. ROWNTREE LC, Audsley J, Allen LF, McQuilten HA, et al
     SARS-CoV-2-specific CD8(+) T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years.
     Proc Natl Acad Sci U S A. 2024;121:e2411428121.
     PubMed     Abstract available
     
     
     
132. CORRIGAN NM, Rokem A, Kuhl PK
     COVID-19 lockdown effects on adolescent brain structure suggest accelerated maturation that is more pronounced in females than in males.
     Proc Natl Acad Sci U S A. 2024;121:e2403200121.
     PubMed     Abstract available
     
     
     
133. LOY CJ, Servellita V, Sotomayor-Gonzalez A, Bliss A, et al
     Plasma cell-free RNA signatures of inflammatory syndromes in children.
     Proc Natl Acad Sci U S A. 2024;121:e2403897121.
     PubMed     Abstract available
     
     
     
134. HATTORI SI, Bulut H, Hayashi H, Kishimoto N, et al
     Structural and virologic mechanism of the emergence of resistance to M(pro) inhibitors in SARS-CoV-2.
     Proc Natl Acad Sci U S A. 2024;121:e2404175121.
     PubMed     Abstract available
     
     
     August 2024
135. ABBATE MF, Dupic T, Vigne E, Shahsavarian MA, et al
     Computational detection of antigen-specific B cell receptors following immunization.
     Proc Natl Acad Sci U S A. 2024;121:e2401058121.
     PubMed     Abstract available
     
     
     
136. ILLIBAUER J, Clodi-Seitz T, Zoufaly A, Aberle JH, et al
     Diagnostic potential of blood plasma longitudinal viscosity measured using Brillouin light scattering.
     Proc Natl Acad Sci U S A. 2024;121:e2323016121.
     PubMed     Abstract available
     
     
     
137. ROSS SL, Jiang S, Young MF, Meyer JL, et al
     In-person learning during the pandemic: Student take-up and school-level effects of remote and hybrid instruction on student outcomes.
     Proc Natl Acad Sci U S A. 2024;121:e2407322121.
     PubMed     Abstract available
     
     
     
138. ROCKEY NC, Le Sage V, Shephard M, Vargas-Maldonado N, et al
     Ventilation does not affect close-range transmission of influenza virus in a ferret playpen setup.
     Proc Natl Acad Sci U S A. 2024;121:e2322660121.
     PubMed     Abstract available
     
     
     
139. ZHANG W, Shi K, Hsueh FC, Mendoza A, et al
     Structural basis for mouse receptor recognition by bat SARS2-like coronaviruses.
     Proc Natl Acad Sci U S A. 2024;121:e2322600121.
     PubMed     Abstract available
     
     
     
140. MUHLEMANN B, Trimpert J, Walper F, Schmidt ML, et al
     Antigenic cartography using variant-specific hamster sera reveals substantial antigenic variation among Omicron subvariants.
     Proc Natl Acad Sci U S A. 2024;121:e2310917121.
     PubMed     Abstract available
     
     
     July 2024
141. ROACH SN, Shepherd FK, Mickelson CK, Fiege JK, et al
     Tropism for ciliated cells is the dominant driver of influenza viral burst size in the human airway.
     Proc Natl Acad Sci U S A. 2024;121:e2320303121.
     PubMed     Abstract available
     
     
     
142. GAGLIONE SA, Rosales TJ, Schmidt-Hong L, Baker BM, et al
     SARS-CoV-2 spike does not interact with the T cell receptor or directly activate T cells.
     Proc Natl Acad Sci U S A. 2024;121:e2406615121.
     PubMed     Abstract available
     
     
     
143. LEIBEL SL, McVicar RN, Murad R, Kwong EM, et al
     A therapy for suppressing canonical and noncanonical SARS-CoV-2 viral entry and an intrinsic intrapulmonary inflammatory response.
     Proc Natl Acad Sci U S A. 2024;121:e2408109121.
     PubMed     Abstract available
     
     
     
144. GUARNIERI JW, Lie T, Albrecht YES, Hewin P, et al
     Mitochondrial antioxidants abate SARS-COV-2 pathology in mice.
     Proc Natl Acad Sci U S A. 2024;121:e2321972121.
     PubMed     Abstract available
     
     
     
145. FERRER-ORTA C, Vazquez-Monteagudo S, Ferrero DS, Martinez-Gonzalez B, et al
     Point mutations at specific sites of the nsp12-nsp8 interface dramatically affect the RNA polymerization activity of SARS-CoV-2.
     Proc Natl Acad Sci U S A. 2024;121:e2317977121.
     PubMed     Abstract available
     
     
     
146. PERLMAN S
     A balance between innovation and biosafety.
     Proc Natl Acad Sci U S A. 2024;121:e2410451121.
     PubMed    
     
     
     
147. HU Z, Lopez-Munoz AD, Kosik I, Li T, et al
     Recombinant OC43 SARS-CoV-2 spike replacement virus: An improved BSL-2 proxy virus for SARS-CoV-2 neutralization assays.
     Proc Natl Acad Sci U S A. 2024;121:e2310421121.
     PubMed     Abstract available
     
     
     
148. WU Q, Rafatian N, Wagner KT, Blamer J, et al
     SARS-CoV-2 pathogenesis in an angiotensin II-induced heart-on-a-chip disease model and extracellular vesicle screening.
     Proc Natl Acad Sci U S A. 2024;121:e2403581121.
     PubMed     Abstract available
     
     
     
149. PURCELL H, Kohler IV, Ciancio A, Mwera J, et al
     Mortality risk information and health-seeking behavior during an epidemic.
     Proc Natl Acad Sci U S A. 2024;121:e2315677121.
     PubMed     Abstract available
     
     
     
150. DE LA PRADA AG, Small ML
     How people are exposed to neighborhoods racially different from their own.
     Proc Natl Acad Sci U S A. 2024;121:e2401661121.
     PubMed     Abstract available
     
     
     June 2024
151. KIM H, Park HH, Kim HN, Seo D, et al
     The TOX-RAGE axis mediates inflammatory activation and lung injury in severe pulmonary infectious diseases.
     Proc Natl Acad Sci U S A. 2024;121:e2319322121.
     PubMed     Abstract available
     
     
     
152. TORTORICE D, Rappuoli R, Bloom DE
     The economic case for scaling up health research and development: Lessons from the COVID-19 pandemic.
     Proc Natl Acad Sci U S A. 2024;121:e2321978121.
     PubMed     Abstract available
     
     
     
153. GUILLEN JV, Glaunsinger BA
     SARS-CoV-2 Nsp1 traps RNA in the nucleus to escape immune detection.
     Proc Natl Acad Sci U S A. 2024;121:e2408794121.
     PubMed    
     
     
     
154. DONKER T, Papathanassopoulos A, Ghosh H, Kociurzynski R, et al
     Estimation of SARS-CoV-2 fitness gains from genomic surveillance data without prior lineage classification.
     Proc Natl Acad Sci U S A. 2024;121:e2314262121.
     PubMed     Abstract available
     
     
     
155. AFROZ S, Saul S, Dai J, Surman S, et al
     Human parainfluenza virus 3 vaccine candidates attenuated by codon-pair deoptimization are immunogenic and protective in hamsters.
     Proc Natl Acad Sci U S A. 2024;121:e2316376121.
     PubMed     Abstract available
     
     
     
156. MCGOUGH L, Cobey S
     A speed limit on serial strain replacement from original antigenic sin.
     Proc Natl Acad Sci U S A. 2024;121:e2400202121.
     PubMed     Abstract available
     
     
     
157. GUO YT, Jiang JB, Qiao GR, Luo RH, et al
     Pleiotropy of positive selection in ancient ACE2 suggests an alternative hypothesis for bat-specific adaptations to host coronaviruses.
     Proc Natl Acad Sci U S A. 2024;121:e2321619121.
     PubMed     Abstract available
     
     
     
158. WANG D, Huot M, Mohanty V, Shakhnovich EI, et al
     Biophysical principles predict fitness of SARS-CoV-2 variants.
     Proc Natl Acad Sci U S A. 2024;121:e2314518121.
     PubMed     Abstract available
     
     
     
159. QU B, Miskey C, Gomer A, Kleinert RDV, et al
     TMPRSS2-mediated SARS-CoV-2 uptake boosts innate immune activation, enhances cytopathology, and drives convergent virus evolution.
     Proc Natl Acad Sci U S A. 2024;121:e2407437121.
     PubMed     Abstract available
     
     
     May 2024
160. KITAMURA S, Lin TH, Lee CD, Takamura A, et al
     Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry.
     Proc Natl Acad Sci U S A. 2024;121:e2310677121.
     PubMed     Abstract available
     
     
     
161. LICHAND G, Doria CA
     The lasting impacts of remote learning in the absence of remedial policies: Evidence from Brazil.
     Proc Natl Acad Sci U S A. 2024;121:e2316300121.
     PubMed     Abstract available
     
     
     
162. LAL A, Thompson DM
     Did private election administration funding advantage Democrats in 2020?
     Proc Natl Acad Sci U S A. 2024;121:e2317563121.
     PubMed     Abstract available
     
     
     
163. ENDEVELT K, Halperin E, Porat R
     Zoom out: An intervention on the virtual learning environment improves minority students' grades in two field experiments in Israel.
     Proc Natl Acad Sci U S A. 2024;121:e2313496121.
     PubMed     Abstract available
     
     
     
164. MEI M, Cupic A, Miorin L, Ye C, et al
     Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis.
     Proc Natl Acad Sci U S A. 2024;121:e2314166121.
     PubMed     Abstract available
     
     
     
165. OTTER CJ, Renner DM, Fausto A, Tan LH, et al
     Interferon signaling in the nasal epithelium distinguishes among lethal and common cold coronaviruses and mediates viral clearance.
     Proc Natl Acad Sci U S A. 2024;121:e2402540121.
     PubMed     Abstract available
     
     
     
166. XIE Y, Yang F, Huang J, He Y, et al
     Declining Chinese attitudes toward the United States amid COVID-19.
     Proc Natl Acad Sci U S A. 2024;121:e2322920121.
     PubMed     Abstract available
     
     
     
167. MORALES M, Yang MY, Goddard WA 3rd, Gray HB, et al
     Copper(II) coordination to the intrinsically disordered region of SARS-CoV-2 Nsp1.
     Proc Natl Acad Sci U S A. 2024;121:e2402653121.
     PubMed     Abstract available
     
     
     April 2024
168. MAO T, Kim J, Pena-Hernandez MA, Valle G, et al
     Intranasal neomycin evokes broad-spectrum antiviral immunity in the upper respiratory tract.
     Proc Natl Acad Sci U S A. 2024;121:e2319566121.
     PubMed     Abstract available
     
     
     
169. KUNG CSJ, Steptoe A
     Changes in well-being among socially isolated older people during the COVID-19 pandemic: An outcome-wide analysis.
     Proc Natl Acad Sci U S A. 2024;121:e2308697121.
     PubMed     Abstract available
     
     
     
170. FREEDMAN AS, Sheen JK, Tsai S, Yao J, et al
     Inferring COVID-19 testing and vaccination behavior from New Jersey testing data.
     Proc Natl Acad Sci U S A. 2024;121:e2314357121.
     PubMed     Abstract available
     
     
     
171. JOHANNESEN N, Tang-Andersen Martinello A, Meyer BB, Vestergaard ET, et al
     Substantial transmission of SARS-CoV-2 through casual contact in retail stores: Evidence from matched administrative microdata on card payments and testing.
     Proc Natl Acad Sci U S A. 2024;121:e2317589121.
     PubMed     Abstract available
     
     
     
172. OTTER CJ, Bracci N, Parenti NA, Ye C, et al
     SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling.
     Proc Natl Acad Sci U S A. 2024;121:e2320194121.
     PubMed     Abstract available
     
     
     
173. TAN TJC, Verma AK, Odle A, Lei R, et al
     Evidence of antigenic drift in the fusion machinery core of SARS-CoV-2 spike.
     Proc Natl Acad Sci U S A. 2024;121:e2317222121.
     PubMed     Abstract available
     
     
     
174. BABOUN J, Beaudry IS, Castro LM, Gutierrez F, et al
     Identifying outbreaks in sewer networks: An adaptive sampling scheme under network's uncertainty.
     Proc Natl Acad Sci U S A. 2024;121:e2316616121.
     PubMed     Abstract available
     
     
     March 2024
175. FLECKENSTEIN F, Stephan S, Hasse H
     Elucidating the behavior of the SARS-CoV-2 virus surface at vapor-liquid interfaces using molecular dynamics simulation.
     Proc Natl Acad Sci U S A. 2024;121:e2317194121.
     PubMed     Abstract available
     
     
     
176. GAO R, Xu X, Kumar P, Liu Y, et al
     Tapered chiral nanoparticles as broad-spectrum thermally stable antivirals for SARS-CoV-2 variants.
     Proc Natl Acad Sci U S A. 2024;121:e2310469121.
     PubMed     Abstract available
     
     
     
177. CAHUANTZI R, Lythgoe KA, Hall I, Pellis L, et al
     Unsupervised identification of significant lineages of SARS-CoV-2 through scalable machine learning methods.
     Proc Natl Acad Sci U S A. 2024;121:e2317284121.
     PubMed     Abstract available
     
     
     
178. DELGADO S, Somovilla P, Ferrer-Orta C, Martinez-Gonzalez B, et al
     Incipient functional SARS-CoV-2 diversification identified through neural network haplotype maps.
     Proc Natl Acad Sci U S A. 2024;121:e2317851121.
     PubMed     Abstract available
     
     
     
179. LIAO Z, Wang C, Tang X, Yang M, et al
     Human transferrin receptor can mediate SARS-CoV-2 infection.
     Proc Natl Acad Sci U S A. 2024;121:e2317026121.
     PubMed     Abstract available
     
     
     
180. CHANG S, Shin KS, Park B, Park S, et al
     Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform.
     Proc Natl Acad Sci U S A. 2024;121:e2313681121.
     PubMed     Abstract available
     
     
     
181. KRETSCH RC, Xu L, Zheludev IN, Zhou X, et al
     Tertiary folds of the SL5 RNA from the 5' proximal region of SARS-CoV-2 and related coronaviruses.
     Proc Natl Acad Sci U S A. 2024;121:e2320493121.
     PubMed     Abstract available
     
     
     February 2024
182. RAINS SA, Richards AS
     US state vaccine mandates did not influence COVID-19 vaccination rates but reduced uptake of COVID-19 boosters and flu vaccines compared to bans on vaccine restrictions.
     Proc Natl Acad Sci U S A. 2024;121:e2313610121.
     PubMed     Abstract available
     
     
     
183. ZHAO G, Xue L, Geisler HC, Xu J, et al
     Precision treatment of viral pneumonia through macrophage-targeted lipid nanoparticle delivery.
     Proc Natl Acad Sci U S A. 2024;121:e2314747121.
     PubMed     Abstract available
     
     
     
184. ZHANG Y, Bharathi V, Dokoshi T, de Anda J, et al
     Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes.
     Proc Natl Acad Sci U S A. 2024;121:e2300644120.
     PubMed     Abstract available
     
     
     
185. PAGLINO E, Lundberg DJ, Wrigley-Field E, Zhou Z, et al
     Excess natural-cause mortality in US counties and its association with reported COVID-19 deaths.
     Proc Natl Acad Sci U S A. 2024;121:e2313661121.
     PubMed     Abstract available
     
     
     January 2024
186. MEYNIEL-SCHICKLIN L, Amaudrut J, Mallinjoud P, Guillier F, et al
     Viruses traverse the human proteome through peptide interfaces that can be biomimetically leveraged for drug discovery.
     Proc Natl Acad Sci U S A. 2024;121:e2308776121.
     PubMed     Abstract available
     
     
     
187. PACIELLO I, Maccari G, Pantano E, Andreano E, et al
     High-resolution map of the Fc functions mediated by COVID-19-neutralizing antibodies.
     Proc Natl Acad Sci U S A. 2024;121:e2314730121.
     PubMed     Abstract available
     
     
     
188. DEE TS
     Higher chronic absenteeism threatens academic recovery from the COVID-19 pandemic.
     Proc Natl Acad Sci U S A. 2024;121:e2312249121.
     PubMed     Abstract available
     
     
     
189. GOTTLIEB A, Pham HPT, Saltarrelli JG, Lindsey JW, et al
     Expanded T lymphocytes in the cerebrospinal fluid of multiple sclerosis patients are specific for Epstein-Barr-virus-infected B cells.
     Proc Natl Acad Sci U S A. 2024;121:e2315857121.
     PubMed     Abstract available
     
     
     
190. YU J, Zhao W, Chen X, Lu H, et al
     A plant virus manipulates the long-winged morph of insect vectors.
     Proc Natl Acad Sci U S A. 2024;121:e2315341121.
     PubMed     Abstract available
     
     
     
191. BAUM MY, Jacob BA
     Racial differences in parent response to COVID schooling policies.
     Proc Natl Acad Sci U S A. 2024;121:e2307308120.
     PubMed     Abstract available
     
     
     
192. DIDIER G, Glatt-Holtz NE, Holbrook AJ, Magee AF, et al
     On the surprising effectiveness of a simple matrix exponential derivative approximation, with application to global SARS-CoV-2.
     Proc Natl Acad Sci U S A. 2024;121:e2318989121.
     PubMed     Abstract available
     
     
     
193. VAUGHAN TG, Scire J, Nadeau SA, Stadler T, et al
     Estimates of early outbreak-specific SARS-CoV-2 epidemiological parameters from genomic data.
     Proc Natl Acad Sci U S A. 2024;121:e2308125121.
     PubMed     Abstract available
     
     
     
194. FINNEY J, Moseman AP, Kong S, Watanabe A, et al
     Protective human antibodies against a conserved epitope in pre- and postfusion influenza hemagglutinin.
     Proc Natl Acad Sci U S A. 2024;121:e2316964120.
     PubMed     Abstract available
     
     
     
195. CHEN Y, Gel YR, Marathe MV, Poor HV, et al
     A simplicial epidemic model for COVID-19 spread analysis.
     Proc Natl Acad Sci U S A. 2024;121:e2313171120.
     PubMed     Abstract available
     
     
     December 2023
196. RAO X, Zhao R, Tong Z, Guo S, et al
     Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2.
     Proc Natl Acad Sci U S A. 2023;120:e2314193120.
     PubMed     Abstract available
     
     
     
197. YE Z, Bonam SR, McKay LGA, Plante JA, et al
     Monovalent SARS-COV-2 mRNA vaccine using optimal UTRs and LNPs is highly immunogenic and broadly protective against Omicron variants.
     Proc Natl Acad Sci U S A. 2023;120:e2311752120.
     PubMed     Abstract available
     
     
     
198. MIYAMOTO S, Nishiyama T, Ueno A, Park H, et al
     Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection.
     Proc Natl Acad Sci U S A. 2023;120:e2314808120.
     PubMed     Abstract available
     
     
     
199. STUMPFF JP 2ND, Kim SY, McFadden MI, Nishida A, et al
     Pleural macrophages translocate to the lung during infection to promote improved influenza outcomes.
     Proc Natl Acad Sci U S A. 2023;120:e2300474120.
     PubMed     Abstract available
     
     
     
200. NAPOLI L, Sekara V, Garcia-Herranz M, Karsai M, et al
     Socioeconomic reorganization of communication and mobility networks in response to external shocks.
     Proc Natl Acad Sci U S A. 2023;120:e2305285120.
     PubMed     Abstract available
     
     
     
201. ZHANG H, Wang Z, Nguyen HTT, Watson AJ, et al
     Integrin alpha(5)beta(1) contributes to cell fusion and inflammation mediated by SARS-CoV-2 spike via RGD-independent interaction.
     Proc Natl Acad Sci U S A. 2023;120:e2311913120.
     PubMed     Abstract available
     
     
     
202. IOANNIDIS JPA, Zonta F, Levitt M
     Variability in excess deaths across countries with different vulnerability during 2020-2023.
     Proc Natl Acad Sci U S A. 2023;120:e2309557120.
     PubMed     Abstract available
     
     
     
203. TURNER CA, Khalil H, Murphy-Weinberg V, Hagenauer MH, et al
     The impact of COVID-19 on a college freshman sample reveals genetic and nongenetic forms of susceptibility and resilience to stress.
     Proc Natl Acad Sci U S A. 2023;120:e2305779120.
     PubMed     Abstract available
     
     
     
204. TORCHE F, Nobles J
     Vaccination, immunity, and the changing impact of COVID-19 on infant health.
     Proc Natl Acad Sci U S A. 2023;120:e2311573120.
     PubMed     Abstract available
     
     
     
205. CHENG CW, Wu CY, Wang SW, Chen JY, et al
     Low-sugar universal mRNA vaccine against coronavirus variants with deletion of glycosites in the S2 or stem of SARS-CoV-2 spike messenger RNA (mRNA).
     Proc Natl Acad Sci U S A. 2023;120:e2314392120.
     PubMed     Abstract available
     
     
     November 2023
206. ESPINOZA B, Adiga A, Venkatramanan S, Warren AS, et al
     Coupled models of genomic surveillance and evolving pandemics with applications for timely public health interventions.
     Proc Natl Acad Sci U S A. 2023;120:e2305227120.
     PubMed     Abstract available
     
     
     
207. CONDOR CAPCHA JM, Kamiar A, Robleto E, Saad AG, et al
     Growth hormone-releasing hormone receptor antagonist MIA-602 attenuates cardiopulmonary injury induced by BSL-2 rVSV-SARS-CoV-2 in hACE2 mice.
     Proc Natl Acad Sci U S A. 2023;120:e2308342120.
     PubMed     Abstract available
     
     
     
208. CHEN Y, Lei X, Jiang Z, Humphries F, et al
     Cellular nucleic acid-binding protein restricts SARS-CoV-2 by regulating interferon and disrupting RNA-protein condensates.
     Proc Natl Acad Sci U S A. 2023;120:e2308355120.
     PubMed     Abstract available
     
     
     
209. ALTMEJD A, Ostergren O, Bjorkegren E, Persson T, et al
     Inequality and COVID-19 in Sweden: Relative risks of nine bad life events, by four social gradients, in pandemic vs. prepandemic years.
     Proc Natl Acad Sci U S A. 2023;120:e2303640120.
     PubMed     Abstract available
     
     
     
210. PETRONE ME, Parry R, Mifsud JCO, Van Brussel K, et al
     Evidence for an ancient aquatic origin of the RNA viral order Articulavirales.
     Proc Natl Acad Sci U S A. 2023;120:e2310529120.
     PubMed     Abstract available
     
     
     
211. ZHOU J, Sukhova K, Peacock TP, McKay PF, et al
     Omicron breakthrough infections in vaccinated or previously infected hamsters.
     Proc Natl Acad Sci U S A. 2023;120:e2308655120.
     PubMed     Abstract available
     
     
     October 2023
212. EDGAR JE, Trezise S, Anthony RM, Krammer F, et al
     Antibodies elicited in humans upon chimeric hemagglutinin-based influenza virus vaccination confer FcgammaR-dependent protection in vivo.
     Proc Natl Acad Sci U S A. 2023;120:e2314905120.
     PubMed     Abstract available
     
     
     
213. CHARDES V, Mazzolini A, Mora T, Walczak AM, et al
     Evolutionary stability of antigenically escaping viruses.
     Proc Natl Acad Sci U S A. 2023;120:e2307712120.
     PubMed     Abstract available
     
     
     
214. FISCHER H, Huff M, Anders G, Said N, et al
     Metacognition, public health compliance, and vaccination willingness.
     Proc Natl Acad Sci U S A. 2023;120:e2105425120.
     PubMed     Abstract available
     
     
     
215. WISSLER A, DeWitte SN
     Frailty and survival in the 1918 influenza pandemic.
     Proc Natl Acad Sci U S A. 2023;120:e2304545120.
     PubMed     Abstract available
     
     
     
216. ZHANG J, Tan S, Peng C, Xu X, et al
     Heterogeneous changes in mobility in response to the SARS-CoV-2 Omicron BA.2 outbreak in Shanghai.
     Proc Natl Acad Sci U S A. 2023;120:e2306710120.
     PubMed     Abstract available
     
     
     
217. HART WS, Park H, Jeong YD, Kim KS, et al
     Analysis of the risk and pre-emptive control of viral outbreaks accounting for within-host dynamics: SARS-CoV-2 as a case study.
     Proc Natl Acad Sci U S A. 2023;120:e2305451120.
     PubMed     Abstract available
     
     
     
218. SCHLUTER M, Brelsford C, Ferraro PJ, Orach K, et al
     Unraveling complex causal processes that affect sustainability requires more integration between empirical and modeling approaches.
     Proc Natl Acad Sci U S A. 2023;120:e2215676120.
     PubMed     Abstract available
     
     
     
219. ZHAO P, Liu Q, Ma T, Kang T, et al
     Policy instruments facilitate China's COVID-19 work resumption.
     Proc Natl Acad Sci U S A. 2023;120:e2305692120.
     PubMed     Abstract available
     
     
     
220. XU J, Zhang Y, Qu P, Shamseldin MM, et al
     A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern.
     Proc Natl Acad Sci U S A. 2023;120:e2220403120.
     PubMed     Abstract available
     
     
     September 2023
221. HUANG R, Warner Jenkins G, Kim Y, Stanfield RL, et al
     The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2.
     Proc Natl Acad Sci U S A. 2023;120:e2303455120.
     PubMed     Abstract available
     
     
     
222. TAO Y, Yang L, Jaffe S, Amini F, et al
     Climate mitigation potentials of teleworking are sensitive to changes in lifestyle and workplace rather than ICT usage.
     Proc Natl Acad Sci U S A. 2023;120:e2304099120.
     PubMed     Abstract available
     
     
     
223. GUSEMAN AJ, Rennick LJ, Nambulli S, Roy CN, et al
     Targeting spike glycans to inhibit SARS-CoV2 viral entry.
     Proc Natl Acad Sci U S A. 2023;120:e2301518120.
     PubMed     Abstract available
     
     
     
224. XU H, Zhong Y, Yang J, Fu L, et al
     Reply to Yan et al.: Quercetin possesses a fluorescence quenching effect but is a weak inhibitor against SARS-CoV-2 main protease.
     Proc Natl Acad Sci U S A. 2023;120:e2309870120.
     PubMed    
     
     
     
225. YAN H, Zhang R, Liu X, Wang Y, et al
     Reframing quercetin as a promiscuous inhibitor against SARS-CoV-2 main protease.
     Proc Natl Acad Sci U S A. 2023;120:e2309289120.
     PubMed    
     
     
     August 2023
226. ZHANG Q
     Complex Interplay between Population Immunity and Viral Dynamics.
     Proc Natl Acad Sci U S A. 2023;120:e2312198120.
     PubMed    
     
     
     
227. ALHAMMAD YM, Parthasarathy S, Ghimire R, Kerr CM, et al
     SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice.
     Proc Natl Acad Sci U S A. 2023;120:e2302083120.
     PubMed     Abstract available
     
     
     
228. CIROVIC A, Cirovic A
     Could iron deficiency potentiate the appearance of complications in Influenza A virus infection?
     Proc Natl Acad Sci U S A. 2023;120:e2311262120.
     PubMed    
     
     
     
229. BOLTON MJ, Santos JJS, Arevalo CP, Griesman T, et al
     IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding.
     Proc Natl Acad Sci U S A. 2023;120:e2216521120.
     PubMed     Abstract available
     
     
     
230. RAO Z, Brunner E, Giszas B, Iyer-Bierhoff A, et al
     Glucocorticoids regulate lipid mediator networks by reciprocal modulation of 15-lipoxygenase isoforms affecting inflammation resolution.
     Proc Natl Acad Sci U S A. 2023;120:e2302070120.
     PubMed     Abstract available
     
     
     
231. BAILEY MJ, Currie J, Schwandt H
     The COVID-19 baby bump in the United States.
     Proc Natl Acad Sci U S A. 2023;120:e2222075120.
     PubMed     Abstract available
     
     
     
232. STAQUICINI DI, Cardo-Vila M, Rotolo JA, Staquicini FI, et al
     Ceramide as an endothelial cell surface receptor and a lung-specific lipid vascular target for circulating ligands.
     Proc Natl Acad Sci U S A. 2023;120:e2220269120.
     PubMed     Abstract available
     
     
     
233. WANG PY, Ma J, Kim YC, Son AY, et al
     WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome.
     Proc Natl Acad Sci U S A. 2023;120:e2302738120.
     PubMed     Abstract available
     
     
     
234. MANRUBIA S, Cuesta JA
     Physics of diffusion in viral genome evolution.
     Proc Natl Acad Sci U S A. 2023;120:e2310999120.
     PubMed    
     
     
     
235. MAIO N, Raza MK, Li Y, Zhang DL, et al
     An iron-sulfur cluster in the zinc-binding domain of the SARS-CoV-2 helicase modulates its RNA-binding and -unwinding activities.
     Proc Natl Acad Sci U S A. 2023;120:e2303860120.
     PubMed     Abstract available
     
     
     
236. ZELLER MA, Ma J, Wong FY, Tum S, et al
     The genomic landscape of swine influenza A viruses in Southeast Asia.
     Proc Natl Acad Sci U S A. 2023;120:e2301926120.
     PubMed     Abstract available
     
     
     
237. YANG L, Wang Z, Wang L, Vrancken B, et al
     Association of vaccination, international travel, public health and social measures with lineage dynamics of SARS-CoV-2.
     Proc Natl Acad Sci U S A. 2023;120:e2305403120.
     PubMed     Abstract available
     
     
     
238. TSANG TK, Wang C, Fang VJ, Perera RAPM, et al
     Reconstructing household transmission dynamics to estimate the infectiousness of asymptomatic influenza virus infections.
     Proc Natl Acad Sci U S A. 2023;120:e2304750120.
     PubMed     Abstract available
     
     
     
239. SHEPHERD SJ, Han X, Mukalel AJ, El-Mayta R, et al
     Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines.
     Proc Natl Acad Sci U S A. 2023;120:e2303567120.
     PubMed     Abstract available
     
     
     
240. BILINSKI AM, Salomon JA, Hatfield LA
     Adaptive metrics for an evolving pandemic: A dynamic approach to area-level COVID-19 risk designations.
     Proc Natl Acad Sci U S A. 2023;120:e2302528120.
     PubMed     Abstract available
     
     
     
241. BADER SM, Cooney JP, Sheerin D, Taiaroa G, et al
     SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlates.
     Proc Natl Acad Sci U S A. 2023;120:e2301689120.
     PubMed     Abstract available
     
     
     
242. LIU M, Bakker AS, Narimatsu Y, van Kuppeveld FJM, et al
     H3N2 influenza A virus gradually adapts to human-type receptor binding and entry specificity after the start of the 1968 pandemic.
     Proc Natl Acad Sci U S A. 2023;120:e2304992120.
     PubMed     Abstract available
     
     
     
243. KESHAVIAH A, Huff I, Hu XC, Guidry V, et al
     Separating signal from noise in wastewater data: An algorithm to identify community-level COVID-19 surges in real time.
     Proc Natl Acad Sci U S A. 2023;120:e2216021120.
     PubMed     Abstract available
     
     
     
244. CHANG TY, Jacobson M, Shah M, Kopetsky M, et al
     Reminders, but not monetary incentives, increase COVID-19 booster uptake.
     Proc Natl Acad Sci U S A. 2023;120:e2302725120.
     PubMed     Abstract available
     
     
     
245. LI P, Xue B, Schnicker NJ, Wong LR, et al
     Nsp3-N interactions are critical for SARS-CoV-2 fitness and virulence.
     Proc Natl Acad Sci U S A. 2023;120:e2305674120.
     PubMed     Abstract available
     
     
     
246. CHAN JCK, Ahn D
     Unproctored online exams provide meaningful assessment of student learning.
     Proc Natl Acad Sci U S A. 2023;120:e2302020120.
     PubMed     Abstract available
     
     
     July 2023
247. ALTANGEREL N, Neuman BW, Hemmer PR, Yakovlev VV, et al
     Label-free drug interaction screening via Raman microscopy.
     Proc Natl Acad Sci U S A. 2023;120:e2218826120.
     PubMed     Abstract available
     
     
     
248. QIAO Y, Wotring JW, Zheng Y, Zhang CJ, et al
     Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response.
     Proc Natl Acad Sci U S A. 2023;120:e2221809120.
     PubMed     Abstract available
     
     
     
249. GOIRIZ L, Ruiz R, Garibo-I-Orts O, Conejero JA, et al
     A variant-dependent molecular clock with anomalous diffusion models SARS-CoV-2 evolution in humans.
     Proc Natl Acad Sci U S A. 2023;120:e2303578120.
     PubMed     Abstract available
     
     
     
250. ASANOV I, Asanov AM, Astebro T, Buenstorf G, et al
     System-, teacher-, and student-level interventions for improving participation in online learning at scale in high schools.
     Proc Natl Acad Sci U S A. 2023;120:e2216686120.
     PubMed     Abstract available
     
     
     
251. ZHANG P, Falcone S, Tsybovsky Y, Singh M, et al
     Increased neutralization potency and breadth elicited by a SARS-CoV-2 mRNA vaccine forming virus-like particles.
     Proc Natl Acad Sci U S A. 2023;120:e2305896120.
     PubMed     Abstract available
     
     
     
252. PRASAD PV, Steele MK, Reed C, Meyers LA, et al
     Multimodeling approach to evaluating the efficacy of layering pharmaceutical and nonpharmaceutical interventions for influenza pandemics.
     Proc Natl Acad Sci U S A. 2023;120:e2300590120.
     PubMed     Abstract available
     
     
     
253. LOPEZ-MUNOZ AD, Santos JJS, Yewdell JW
     Cell surface nucleocapsid protein expression: A betacoronavirus immunomodulatory strategy.
     Proc Natl Acad Sci U S A. 2023;120:e2304087120.
     PubMed     Abstract available
     
     
     June 2023
254. JONES NM, Thompson RR, Holman EA, Silver RC, et al
     Idiosyncratic media exposures during a pandemic and their link to well-being, cognition, and behavior over time.
     Proc Natl Acad Sci U S A. 2023;120:e2304550120.
     PubMed     Abstract available
     
     
     
255. THIJSSEN V, Hurdiss DL, Debski-Antoniak OJ, Spence MA, et al
     A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein.
     Proc Natl Acad Sci U S A. 2023;120:e2303292120.
     PubMed     Abstract available
     
     
     
256. LIU K, Tang M, Xu W, Meng X, et al
     An inducible hACE2 transgenic mouse model recapitulates SARS-CoV-2 infection and pathogenesis in vivo.
     Proc Natl Acad Sci U S A. 2023;120:e2207210120.
     PubMed     Abstract available
     
     
     
257. TRAULSEN A, Levin SA, Saad-Roy CM
     Individual costs and societal benefits of interventions during the COVID-19 pandemic.
     Proc Natl Acad Sci U S A. 2023;120:e2303546120.
     PubMed     Abstract available
     
     
     
258. MISSON MINDREBO L, Liu H, Ozorowski G, Tran Q, et al
     Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulins.
     Proc Natl Acad Sci U S A. 2023;120:e2216612120.
     PubMed     Abstract available
     
     
     
259. SOOD M, Sridhar A, Eletreby R, Wu CW, et al
     Spreading processes with mutations over multilayer networks.
     Proc Natl Acad Sci U S A. 2023;120:e2302245120.
     PubMed     Abstract available
     
     
     
260. GUENTHOER J, Lilly M, Starr TN, Dadonaite B, et al
     Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection.
     Proc Natl Acad Sci U S A. 2023;120:e2220948120.
     PubMed     Abstract available
     
     
     
261. TADA T, Minnee J, Landau NR
     Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical model.
     Proc Natl Acad Sci U S A. 2023;120:e2303509120.
     PubMed     Abstract available
     
     
     May 2023
262. PETERSEN M, Nagele FL, Mayer C, Schell M, et al
     Brain imaging and neuropsychological assessment of individuals recovered from a mild to moderate SARS-CoV-2 infection.
     Proc Natl Acad Sci U S A. 2023;120:e2217232120.
     PubMed     Abstract available
     
     
     
263. PANDEY JP
     Consideration of C1q and FcRn binding to allotypically disparate IgG3 could aid in engineering more efficacious anti-SARS-CoV-2 mAbs.
     Proc Natl Acad Sci U S A. 2023;120:e2306078120.
     PubMed    
     
     
     
264. PARK SW, Sun K, Abbott S, Sender R, et al
     Inferring the differences in incubation-period and generation-interval distributions of the Delta and Omicron variants of SARS-CoV-2.
     Proc Natl Acad Sci U S A. 2023;120:e2221887120.
     PubMed     Abstract available
     
     
     
265. HOSOYA T, Oba S, Komiya Y, Kawata D, et al
     Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19.
     Proc Natl Acad Sci U S A. 2023;120:e2300155120.
     PubMed     Abstract available
     
     
     
266. SCHUMM B, Bremer S, Knodlseder K, Schonfelder M, et al
     Lung aerosol particle emission increases with age at rest and during exercise.
     Proc Natl Acad Sci U S A. 2023;120:e2301145120.
     PubMed     Abstract available
     
     
     
267. MAZEL-SANCHEZ B, Niu C, Williams N, Bachmann M, et al
     Influenza A virus exploits transferrin receptor recycling to enter host cells.
     Proc Natl Acad Sci U S A. 2023;120:e2214936120.
     PubMed     Abstract available
     
     
     
268. BARRETO EA, Cruz AS, Veras FP, Martins R, et al
     COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis.
     Proc Natl Acad Sci U S A. 2023;120:e2217119120.
     PubMed     Abstract available
     
     
     
269. TREVISIN C, Bertuzzo E, Pasetto D, Mari L, et al
     Spatially explicit effective reproduction numbers from incidence and mobility data.
     Proc Natl Acad Sci U S A. 2023;120:e2219816120.
     PubMed     Abstract available
     
     
     
270. HARTON M, Kinzy TG, Bear A
     Monitoring and addressing the long-term impacts of the COVID-19 pandemic on women in academic science, engineering, and medicine.
     Proc Natl Acad Sci U S A. 2023;120:e2304603120.
     PubMed    
     
     
     
271. EASTERLIN RA, O'Connor KJ
     Three years of COVID-19 and life satisfaction in Europe: A macro view.
     Proc Natl Acad Sci U S A. 2023;120:e2300717120.
     PubMed     Abstract available
     
     
     
272. SHEA K, Borchering RK, Probert WJM, Howerton E, et al
     Multiple models for outbreak decision support in the face of uncertainty.
     Proc Natl Acad Sci U S A. 2023;120:e2207537120.
     PubMed     Abstract available
     
     
     
273. SONG Y, Yao H, Wu N, Xu J, et al
     In situ architecture and membrane fusion of SARS-CoV-2 Delta variant.
     Proc Natl Acad Sci U S A. 2023;120:e2213332120.
     PubMed     Abstract available
     
     
     
274. EINAV L, Finkelstein A
     The risk of losing health insurance in the United States is large, and remained so after the Affordable Care Act.
     Proc Natl Acad Sci U S A. 2023;120:e2222100120.
     PubMed     Abstract available
     
     
     
275. XU H, Li S, Liu J, Cheng J, et al
     Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19.
     Proc Natl Acad Sci U S A. 2023;120:e2301775120.
     PubMed     Abstract available
     
     
     April 2023
276. LI C, Huang J, Yu Y, Wan Z, et al
     Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants.
     Proc Natl Acad Sci U S A. 2023;120:e2300376120.
     PubMed     Abstract available
     
     
     
277. ZHANG J, Yang W, Roy S, Liu H, et al
     Tight junction protein occludin is an internalization factor for SARS-CoV-2 infection and mediates virus cell-to-cell transmission.
     Proc Natl Acad Sci U S A. 2023;120:e2218623120.
     PubMed     Abstract available
     
     
     
278. GUINAT C, Tang H, Yang Q, Valenzuela Agui C, et al
     Bayesian phylodynamics reveals the transmission dynamics of avian influenza A(H7N9) virus at the human-live bird market interface in China.
     Proc Natl Acad Sci U S A. 2023;120:e2215610120.
     PubMed     Abstract available
     
     
     
279. LEE CY, Raghunathan V, Caceres CJ, Geiger G, et al
     Epistasis reduces fitness costs of influenza A virus escape from stem-binding antibodies.
     Proc Natl Acad Sci U S A. 2023;120:e2208718120.
     PubMed     Abstract available
     
     
     
280. MORIYAMA M, Lucas C, Monteiro VS, Iwasaki A, et al
     Enhanced inhibition of MHC-I expression by SARS-CoV-2 Omicron subvariants.
     Proc Natl Acad Sci U S A. 2023;120:e2221652120.
     PubMed     Abstract available
     
     
     
281. PIZZIOL V, Demaj X, Di Paolo R, Capraro V, et al
     Political ideology and generosity around the globe.
     Proc Natl Acad Sci U S A. 2023;120:e2219676120.
     PubMed     Abstract available
     
     
     
282. IZADI A, Hailu A, Godzwon M, Wrighton S, et al
     Subclass-switched anti-spike IgG3 oligoclonal cocktails strongly enhance Fc-mediated opsonization.
     Proc Natl Acad Sci U S A. 2023;120:e2217590120.
     PubMed     Abstract available
     
     
     
283. OTTER CJ, Fausto A, Tan LH, Khosla AS, et al
     Infection of primary nasal epithelial cells differentiates among lethal and seasonal human coronaviruses.
     Proc Natl Acad Sci U S A. 2023;120:e2218083120.
     PubMed     Abstract available
     
     
     March 2023
284. ARPINO B, Bordone V, Di Gessa G
     COVID-19 precautionary behaviors and vaccine acceptance among older individuals: The role of close kin.
     Proc Natl Acad Sci U S A. 2023;120:e2214382120.
     PubMed     Abstract available
     
     
     
285. YANG K, Wang C, Kreutzberger AJB, White KI, et al
     Structure-based design of a SARS-CoV-2 Omicron-specific inhibitor.
     Proc Natl Acad Sci U S A. 2023;120:e2300360120.
     PubMed     Abstract available
     
     
     
286. HUMBERT M, Olofsson A, Wullimann D, Niessl J, et al
     Functional SARS-CoV-2 cross-reactive CD4(+) T cells established in early childhood decline with age.
     Proc Natl Acad Sci U S A. 2023;120:e2220320120.
     PubMed     Abstract available
     
     
     
287. KIM Y, Ryu JY, Kim HU, Lee SY, et al
     Computational prediction of interactions between Paxlovid and prescription drugs.
     Proc Natl Acad Sci U S A. 2023;120:e2221857120.
     PubMed     Abstract available
     
     
     
288. G MOREIRA T, Gauthier CD, Murphy L, Lanser TB, et al
     Nasal administration of anti-CD3 mAb (Foralumab) downregulates NKG7 and increases TGFB1 and GIMAP7 expression in T cells in subjects with COVID-19.
     Proc Natl Acad Sci U S A. 2023;120:e2220272120.
     PubMed     Abstract available
     
     
     
289. SAAR KL, McCorkindale W, Fearon D, Boby M, et al
     Turning high-throughput structural biology into predictive inhibitor design.
     Proc Natl Acad Sci U S A. 2023;120:e2214168120.
     PubMed     Abstract available
     
     
     
290. LIU Z, Zhou J, Wang X, Xu W, et al
     A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates.
     Proc Natl Acad Sci U S A. 2023;120:e2221713120.
     PubMed     Abstract available
     
     
     
291. HARIHARAN VN, Shin M, Chang CW, O'Reilly D, et al
     Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection.
     Proc Natl Acad Sci U S A. 2023;120:e2219523120.
     PubMed     Abstract available
     
     
     
292. MUNOZ-BASAGOITI J, Monteiro FLL, Krumpe LRH, Armario-Najera V, et al
     Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2.
     Proc Natl Acad Sci U S A. 2023;120:e2214561120.
     PubMed     Abstract available
     
     
     
293. STENSETH NC, Schlatte R, Liu X, Pielke R Jr, et al
     How to avoid a local epidemic becoming a global pandemic.
     Proc Natl Acad Sci U S A. 2023;120:e2220080120.
     PubMed     Abstract available
     
     
     
294. CUI L, Fang Z, De Souza CM, Lerbs T, et al
     Innate immune cell activation causes lung fibrosis in a humanized model of long COVID.
     Proc Natl Acad Sci U S A. 2023;120:e2217199120.
     PubMed     Abstract available
     
     
     
295. HE D, Lin L, Artzy-Randrup Y, Demirhan H, et al
     Resolving the enigma of Iquitos and Manaus: A modeling analysis of multiple COVID-19 epidemic waves in two Amazonian cities.
     Proc Natl Acad Sci U S A. 2023;120:e2211422120.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum